跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Pataday
Approved
STANDARD
Pataday
Alcon Research, Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
50331bbc1af60639
Company
Alcon Research, Ltd.
Type
Standard
Approval Details
Approval Id
50331bbc1af60639
Drug Approval Philippines Name
Pataday
Product Name
Pataday
Registration Number
DR-XY34608
Brand Name
Pataday
Generic Name
Olopatadine Hydrochloride
Dosage Form
Sterile Ophthalmic Solution
Dosage Strength
2 mg/mL (0.2% w/v)
Manufacturer
Alcon Research, Ltd.
Importer
Novartis Healthcare Philippines, Inc.
Company Detail Path
/organization/alcon-research-ltd
Issuance Date
10 June 2023
Expiry Date
22 May 2028
Pharmacologic Category
Antiallergic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
50331bbc1af60639
Type
Standard
Back to Philippines FDA Approvals
Pataday - Philippines FDA Drug Approval Details